Distribution and status of vitamin B12 in Chinese adults with hypertension: a comprehensive report across 14 provinces

Author:

Cao Tianyu1,Huang Xiao2,Chen Ping3,Huang Zena4,Cheng Zaihua2,Lu Wenyang5,Spence J. David6,Shi Hanping7,Cheng Xiaoshu28,Liu Lishun4910

Affiliation:

1. Biological Anthropology, University of California Santa Barbara, CA, USA

2. Department of Cardiology, the Second Affiliated Hospital of Nanchang University, Nanchang, China

3. College of Pharmacy, Jinan University, Guangzhou, China

4. Shenzhen Evergreen Medical Institute, Shenzhen, China

5. Nanchang University Queen Mary School, Nanchang, China

6. Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, Western University, London, ON, Canada

7. Departments of Gastrointestinal Surgery and Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

8. Center for Prevention and Treatment of Cardiovascular Diseases, the Second Affiliated Hospital of Nanchang University, Nanchang, China

9. Institute of Biomedicine, Anhui Medical University, Hefei, China

10. Graduate School at Shenzhen, Tsinghua University, Shenzhen, China.

Abstract

Background: Vitamin B12 (VB12) is an essential biomarker for population health, and its deficiency status leads to severe health burdens. A comprehensive and updated investigation on the distribution of VB12 levels and status is critically needed to address public health and clinical concerns. Methods: We conducted a cross-sectional analysis using data obtained from the Precision Medical Program, which encompassed 14 provinces in China. Specific criteria based on previously published cutoffs and our study population’s characteristics are adopted to define B12 deficiency. Biochemical B12 deficiency was identified with circulating VB12 levels <148 pmol/L. Metabolic B12 deficiency was determined with circulating VB12 levels ≥148 and ≤258 pmol/L with concomitant elevated plasma total homocysteine (tHcy ≥14 µmol/L). Normal B12 status included VB12 levels >258 pmol/L or VB12 levels ranging from 148 to 258 pmol/L with tHcy levels below 14 µmol/L. VB12 levels and status were analyzed and stratified by age, sex, and geographical region. Results: This study enrolled a total of 2174 hypertensive adults, with a mean age of 63.0 years (±13.4) and 45.8% female. The overall mean VB12 levels were 322.3 (85.0) pmol/L. The prevalence rates of B12 biochemical deficiency, metabolic deficiency, metabolic deficiency with excluded renal dysfunction, and adequate status were 0.7%, 13.3%, 11.5%, and 85.9%, respectively. Females exhibited higher VB12 levels than males, with a β value of 19.72 (95% confidence interval [CI], 10.59–28.84) in the multivariate model. The southern population demonstrated higher VB12 levels than people from the north, with a β value of −18.14 (95% CI, −25.72 to −10.76). Males had a higher prevalence of metabolic VB12 deficiency in comparison to females (15.8% vs. 10.4%). Conclusions: Our study revealed that Chinese hypertensive adults exhibit relatively higher levels of VB12. Additionally, while biochemical B12 deficiency is uncommon, a noteworthy proportion of individuals were affected by metabolic VB12 deficiency. This study has important implications for nutritional counseling and vitamin B supplement strategies.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3